Get started
Author

Simon Davy

Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records
2022 · Ellen J. Thompson, Dylan M. Williams, et al. · Nature Communications · 605
PDF
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
2021 · Daniel J Grint, Kevin Wing, et al. · Eurosurveillance · 189
Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY
2021 · The OpenSAFELY Collaborative, Helen J Curtis, et al. · British Journal of General Practice · 173
PDF
Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform
2021 · The OpenSAFELY Collaborative, Elizabeth J Williamson, et al. · BMJ · 120
PDF
Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY
2021 · The OpenSAFELY Collaborative, Alex J Walker, et al. · British Journal of General Practice · 113
PDF
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
2022 · Brian MacKenna, Nicholas A Kennedy, et al. · The Lancet Rheumatology · 108
PDF
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform
2023 · The OpenSAFELY Collaborative, Linda Nab, et al. · The Lancet Public Health · 97
Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England
2021 · Daniel J Grint, Kevin Wing, et al. · Clinical Infectious Diseases · 95
PDF
OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England
2022 · Colm D Andrews, Anna Schultze, et al. · Wellcome Open Research · 90
PDF
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform
2022 · Bang Zheng, Amelia C A Green, et al. · BMJ · 86
PDF
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)
2024 · Oliver Carlile, Andrew Briggs, et al. · The Lancet Regional Health - Europe · 85
PDF
Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65
2022 · Anna Schultze, Emily Nightingale, et al. · The Lancet Regional Health - Europe · 74
PDF
Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people
2022 · Syed Ahmar Shah, Sinead Brophy, et al. · EClinicalMedicine · 71
PDF
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
2022 · Elsie MF Horne, William J Hulme, et al. · BMJ · 61
PDF
Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study
2024 · Genevieve I. Cezard, Rachel E. Denholm, et al. · Nature Communications · 43
PDF
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic
2021 · The OpenSAFELY Collaborative, Helen J Curtis, et al. · Open Heart · 36
PDF
Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England: a descriptive cohort study within the OpenSAFELY platform
2022 · The OpenSAFELY Collaborative, John Tazare, et al. · Wellcome Open Research · 35
PDF
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY
2023 · Amelia C A Green, Helen J Curtis, et al. · BMJ Medicine · 33
PDF
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data
2023 · William J. Hulme, Elizabeth Williamson, et al. · Annals of Internal Medicine · 30
PDF
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform
2022 · Jemma L Walker, Anna Schultze, et al. · Vaccine · 30
PDF
OpenSAFELY NHS Service Restoration Observatory 1: primary care clinical activity in England during the first wave of COVID-19
2021 · The OpenSAFELY Collaborative, Helen J Curtis, et al. · British Journal of General Practice · 30
PDF
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY
2022 · The OpenSAFELY Collaborative:, Amelia Green, et al. · BMC Medicine · 29
PDF
Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people
2024 · Kurt Taylor, Sophie Eastwood, et al. · The Lancet Diabetes & Endocrinology · 28
Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis
2024 · Alasdair D. Henderson, Ben FC. Butler-Cole, et al. · EClinicalMedicine · 24
Identifying Care Home Residents in Electronic Health Records - An OpenSAFELY Short Data Report
2021 · Anna Schultze, Chris Bates, et al. · Wellcome Open Research · 24
PDF
Works count: 84
Citation count: 2,512
H-index: 24
I10-index: 32
Year
Topic
Type